Page last updated: 2024-10-31

mianserin and Reperfusion Injury

mianserin has been researched along with Reperfusion Injury in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tok, A1
Sener, E1
Albayrak, A1
Cetin, N1
Polat, B1
Suleyman, B1
Akcay, F1
Suleyman, H1

Other Studies

1 other study available for mianserin and Reperfusion Injury

ArticleYear
Effect of mirtazapine on oxidative stress created in rat kidneys by ischemia-reperfusion.
    Renal failure, 2012, Volume: 34, Issue:1

    Topics: Animals; Kidney; Male; Mianserin; Mirtazapine; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Inj

2012